These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 9356028)

  • 1. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
    Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
    Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y Y1 receptor antisense oligodeoxynucleotides enhance food intake in energy-deprived rats.
    Schaffhauser AO; Whitebread S; Haener R; Hofbauer KG; Stricker-Krongrad A
    Regul Pept; 1998 Sep; 75-76():417-23. PubMed ID: 9802438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central administration of Y5 receptor antisense decreases spontaneous food intake and attenuates feeding in response to exogenous neuropeptide Y.
    Tang-Christensen M; Kristensen P; Stidsen CE; Brand CL; Larsen PJ
    J Endocrinol; 1998 Nov; 159(2):307-12. PubMed ID: 9795372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feeding response to neuropeptide Y-related compounds in rats treated with Y5 receptor antisense or sense phosphothio-oligodeoxynucleotide.
    Flynn MC; Turrin NP; Plata-Salamán CR; Ffrench-Mullen JM
    Physiol Behav; 1999 Jul; 66(5):881-4. PubMed ID: 10405118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats.
    Lopez-Valpuesta FJ; Nyce JW; Griffin-Biggs TA; Ice JC; Myers RD
    Proc Biol Sci; 1996 Jul; 263(1372):881-6. PubMed ID: 8760491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats.
    Turnbull AV; Ellershaw L; Masters DJ; Birtles S; Boyer S; Carroll D; Clarkson P; Loxham SJ; McAulay P; Teague JL; Foote KM; Pease JE; Block MH
    Diabetes; 2002 Aug; 51(8):2441-9. PubMed ID: 12145156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of specificity of neuropeptide Y (NPY) antisense oligodeoxynucleotides administered intracerebroventricularly in inhibiting food intake and NPY gene expression in the rat hypothalamus.
    Dryden S; Pickavance L; Tidd D; Williams G
    J Endocrinol; 1998 Apr; 157(1):169-75. PubMed ID: 9614370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profiles of adipose tissue of obese rats after central administration of neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides by cDNA microarrays.
    Qiu J; Ni YH; Chen RH; Ji CB; Liu F; Zhang CM; Gao CL; Chen XH; Tong ML; Chi X; Zhou XY; Guo XR
    Peptides; 2008 Nov; 29(11):2052-60. PubMed ID: 18652865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.
    Criscione L; Rigollier P; Batzl-Hartmann C; Rüeger H; Stricker-Krongrad A; Wyss P; Brunner L; Whitebread S; Yamaguchi Y; Gerald C; Heurich RO; Walker MW; Chiesi M; Schilling W; Hofbauer KG; Levens N
    J Clin Invest; 1998 Dec; 102(12):2136-45. PubMed ID: 9854049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic circuitry of neuropeptide Y regulation of neuroendocrine function and food intake via the Y5 receptor subtype.
    Campbell RE; ffrench-Mullen JM; Cowley MA; Smith MS; Grove KL
    Neuroendocrinology; 2001 Aug; 74(2):106-19. PubMed ID: 11474218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of antisense oligodeoxynucleotides to study the physiological functions of neuropeptide Y.
    Kalra PS; Kalra SP
    Methods; 2000 Nov; 22(3):249-54. PubMed ID: 11071820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y5 receptor antagonists as anti-obesity drugs.
    Levens NR; Della-Zuana O
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1198-204. PubMed ID: 14649211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.
    Akabayashi A; Wahlestedt C; Alexander JT; Leibowitz SF
    Brain Res Mol Brain Res; 1994 Jan; 21(1-2):55-61. PubMed ID: 8164522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y effect on food intake in broiler and layer chicks.
    Saneyasu T; Honda K; Kamisoyama H; Ikura A; Nakayama Y; Hasegawa S
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Aug; 159(4):422-6. PubMed ID: 21554973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.
    Heilig M
    Regul Pept; 1995 Oct; 59(2):201-5. PubMed ID: 8584755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-152,804: orally active and selective neuropeptide Y Y5 receptor antagonist.
    Kanatani A; Ishihara A; Iwaasa H; Nakamura K; Okamoto O; Hidaka M; Ito J; Fukuroda T; MacNeil DJ; Van der Ploeg LH; Ishii Y; Okabe T; Fukami T; Ihara M
    Biochem Biophys Res Commun; 2000 May; 272(1):169-73. PubMed ID: 10872822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.